Top ten tips for perfect corona-2 prophylaxis

被引：0
作者：
Ahmad Abul-Ainine [1 ]
Ali A Sadek [1 ]
机构：
[1] MOH
来源：
World Journal of Clinical Infectious Diseases | 2020年 / 04期
关键词：
D O I：
暂无
中图分类号：
R969 [临床药理学];
学科分类号：
100602 ; 100706 ;
摘要：
The current corona-2 pandemic has stimulated wide research for hydroxychloroquine(Quine) therapy and lately, prophylaxis. To optimize prophylaxis proper methods of use are explained. The focus is on tools of assessment and robust comparison; defining infection objectively; loading and maintenance dose designing based on pharmaco-viro-kinetics; confirming Quine threshold-levels and its sufficiency; and Quine side-effects vigilance/amelioration. Attention to statistics to study valid endpoints of goals in appropriately-sized population is essential. Mass interactive quine dose auto designer software is built to simplify, optimize and help collaboration of complex Quine dosing system. A similar chloroquine software can be built.
引用
收藏
页码：55 / 57
页数：3
相关论文
共 6 条
  • [1] Capillary blood collected on volumetric absorptive microsampling （VAMS） device for monitoring hydroxychloroquine in rheumatoid arthritis patients[J] . Ying Qu,Kelley Brady,Robert Apilado,Tyler O’Malley,Smitha Reddy,Puja Chitkara,Claudia Ibarra,Roberta Vezza Alexander,Thierry Dervieux. &nbspJournal of Pharmaceutical and Biomedical Analysis . 2017
  • [2] Hydroxychloroquine,a less toxic derivative of chloroquine,is effective in inhibiting SARS-Co V-2infection in vitro. LIU J,CAO R Y,XU M Y,et al. Cell Discov . 2020
  • [3] In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 （SARS-CoV-2）. Yao X,Ye F,Zhang M,Cui C,Huang B,Niu P,Liu X,Zhao L,Dong E,Song C,Zhan S,Lu R,Li H,Tan W,Liu D. Clinical Infectious Diseases . 2020
  • [4] A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Boulware DR,Pullen MF,Bangdiwala AS,Pastick KA,Lofgren SM,Okafor EC,Skipper CP,Nascene AA,Nicol MR,Abassi M,Engen NW,Cheng MP,LaBar D,Lother SA,MacKenzie LJ,Drobot G,Marten N,Zarychanski R,Kelly LE,Schwartz IS,McDonald EG,Rajasingham R,Lee TC,Hullsiek KH. The New England Journal of Medicine . 2020
  • [5] Interrater reliability: the kappa statistic. Mary L. McHugh. BIOCHEMIA MEDICA . 2012
  • [6] Drug Name:SYMPROIC.FDA-Approved Drugs. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=208854 . 2017
1